Shanghai Kaibao Pharmaceutical CO.,Ltd reported earnings results for the first quarter ended March 31, 2023. For the first quarter, the company reported sales was CNY 459.39 million compared to CNY 343.82 million a year ago. Revenue was CNY 459.39 million compared to CNY 343.82 million a year ago.

Net income was CNY 80.18 million compared to CNY 57.64 million a year ago. Basic earnings per share from continuing operations was CNY 0.0767 compared to CNY 0.0551 a year ago. Diluted earnings per share from continuing operations was CNY 0.0767 compared to CNY 0.0551 a year ago.